Labcorp Gross Margin 2010-2024 | LH
Current and historical gross margin for Labcorp (LH) over the last 10 years. The current gross profit margin for Labcorp as of September 30, 2024 is %.
| Labcorp Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-09-30 |
$12.71B |
$3.55B |
27.91% |
| 2024-06-30 |
$12.49B |
$3.50B |
27.99% |
| 2024-03-31 |
$12.30B |
$3.41B |
27.73% |
| 2023-12-31 |
$12.16B |
$3.36B |
27.66% |
| 2023-09-30 |
$11.30B |
$3.19B |
28.22% |
| 2023-06-30 |
$11.11B |
$3.23B |
29.02% |
| 2023-03-31 |
$11.00B |
$3.33B |
30.23% |
| 2022-12-31 |
$11.87B |
$3.71B |
31.26% |
| 2022-09-30 |
$10.76B |
$3.81B |
35.36% |
| 2022-06-30 |
$11.96B |
$4.31B |
36.00% |
| 2022-03-31 |
$12.88B |
$4.63B |
35.94% |
| 2021-12-31 |
$13.14B |
$4.99B |
38.01% |
| 2021-09-30 |
$16.56B |
$6.16B |
37.18% |
| 2021-06-30 |
$16.39B |
$6.33B |
38.61% |
| 2021-03-31 |
$15.32B |
$5.82B |
38.02% |
| 2020-12-31 |
$13.98B |
$4.95B |
35.43% |
| 2020-09-30 |
$12.44B |
$3.87B |
31.10% |
| 2020-06-30 |
$11.48B |
$3.13B |
27.25% |
| 2020-03-31 |
$11.59B |
$3.19B |
27.54% |
| 2019-12-31 |
$11.56B |
$3.25B |
28.15% |
| 2019-09-30 |
$11.39B |
$3.20B |
28.13% |
| 2019-06-30 |
$11.29B |
$3.18B |
28.13% |
| 2019-03-31 |
$11.28B |
$3.19B |
28.26% |
| 2018-12-31 |
$11.33B |
$3.18B |
28.02% |
| 2018-09-30 |
$11.29B |
$3.22B |
28.53% |
| 2018-06-30 |
$11.08B |
$3.22B |
29.02% |
| 2018-03-31 |
$10.74B |
$3.16B |
29.40% |
| 2017-12-31 |
$10.31B |
$3.09B |
30.00% |
| 2017-09-30 |
$9.90B |
$2.74B |
27.64% |
| 2017-06-30 |
$9.70B |
$2.74B |
28.27% |
| 2017-03-31 |
$9.60B |
$2.79B |
29.06% |
| 2016-12-31 |
$9.55B |
$2.85B |
29.87% |
| 2016-09-30 |
$9.52B |
$3.13B |
32.93% |
| 2016-06-30 |
$9.42B |
$3.11B |
33.03% |
| 2016-03-31 |
$9.26B |
$3.06B |
33.02% |
| 2015-12-31 |
$8.68B |
$2.90B |
33.46% |
| 2015-09-30 |
$7.89B |
$2.71B |
34.34% |
| 2015-06-30 |
$7.13B |
$2.52B |
35.30% |
| 2015-03-31 |
$6.37B |
$2.31B |
36.27% |
| 2014-12-31 |
$6.01B |
$2.20B |
36.66% |
| 2014-09-30 |
$5.94B |
$2.18B |
36.78% |
| 2014-06-30 |
$5.85B |
$2.16B |
36.95% |
| 2014-03-31 |
$5.80B |
$2.17B |
37.39% |
| 2013-12-31 |
$5.81B |
$2.22B |
38.27% |
| 2013-09-30 |
$5.78B |
$2.24B |
38.69% |
| 2013-06-30 |
$5.73B |
$2.24B |
39.12% |
| 2013-03-31 |
$5.69B |
$2.25B |
39.49% |
| 2012-12-31 |
$5.67B |
$2.25B |
39.68% |
| 2012-09-30 |
$5.63B |
$2.26B |
40.17% |
| 2012-06-30 |
$5.62B |
$2.28B |
40.50% |
| 2012-03-31 |
$5.60B |
$2.28B |
40.79% |
| 2011-12-31 |
$5.54B |
$2.28B |
41.05% |
| 2011-09-30 |
$5.47B |
$2.26B |
41.22% |
| 2011-06-30 |
$5.34B |
$2.21B |
41.44% |
| 2011-03-31 |
$5.18B |
$2.16B |
41.71% |
| 2010-12-31 |
$5.00B |
$2.10B |
41.95% |
| 2010-09-30 |
$4.87B |
$2.05B |
41.96% |
| 2010-06-30 |
$4.78B |
$2.02B |
42.14% |
| 2010-03-31 |
$4.73B |
$1.99B |
42.00% |
| 2009-12-31 |
$4.70B |
$1.97B |
41.96% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.046B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
